Pahl , J . H . , Ruslan , S . E . , Buddingh , E . P . , Santos , S . J . , Szuhai , K . , Serra , M . , Gelderblom , H . , Hogendoorn , P . C . , Egeler , R . M . , Schilham , M . W . , Lankester , A . C . 2012 . Anti - EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma . Clin Cancer Res 18 , 432 - 441 .